--Piper Sandler Lowers NextCure's Price Target to $13 From $21, Maintains Overweight Rating
10:05AM ET 5/23/2022 MT NewswiresPrice: 3.80, Change: +0.01, Percent Change: +0.26 ...
Price: 3.80, Change: +0.01, Percent Change: +0.26 ...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Address | 9000 Virginia Manor Road Beltsville, Maryland 20705 |
Phone | +1.240.399.4900 |
Number of Employees | 44 |
Recent SEC Filing | 06/24/2022![]() |
President, Chief Executive Officer & Director | Michael S. Richman |
Chief Operating Officer | Timothy Mayer |
Chief Financial Officer | Steven P. Cobourn |
Chief Scientific Officer | Solomon Langermann |
Price Open | $4.67 |
Previous Close | $4.70 |
52 Week Range | $3.25 - 9.18 |
Market Capitalization | $124.9 M |
Shares Outstanding | 27.7 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 08/04/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$2.66 |
Beta vs. S&P 500 | N/A |
Revenue | $0.00 |
Net Profit Margin | N/A |
Return on Equity | -30.63% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |